Susceptibility to paromomycin in clinical isolates and reference strains of leishmania species responsible for tegumentary leishmaniasis in Brazil

Susceptibility to paromomycin in clinical isolates and reference strains of leishmania species responsible for tegumentary leishmaniasis in Brazil

Elizabeth M. Coser, Bianca A. Ferreira, Edite H. Yamashiro-Kanashiro, José Angelo L. Lindoso, Adriano C. Coelho

ARTIGO

Inglês

Treatment of tegumentary leishmaniasis in Brazil is limited to pentavalent antimonial, amphotericin B and pentamidine. These drugs, administered parenterally, cause several side effects and have a varied clinical response, depending on the species of Leishmania. Urgent expansion of the therapeutic...

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

Fechado

Susceptibility to paromomycin in clinical isolates and reference strains of leishmania species responsible for tegumentary leishmaniasis in Brazil

Elizabeth M. Coser, Bianca A. Ferreira, Edite H. Yamashiro-Kanashiro, José Angelo L. Lindoso, Adriano C. Coelho


										

Susceptibility to paromomycin in clinical isolates and reference strains of leishmania species responsible for tegumentary leishmaniasis in Brazil

Elizabeth M. Coser, Bianca A. Ferreira, Edite H. Yamashiro-Kanashiro, José Angelo L. Lindoso, Adriano C. Coelho

    Fontes

    Acta tropica

    Vol. 215 (Mar., 2021), n. art. 105806